Optometrists in Mesa, AZ Accepting Medicare
148 Optometrists found. Showing 141 - 148
 Neeka G. Najmi, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1840 S Stapley Dr Ste 101, Mesa, AZ 85204 Phone: 800-233-3264 |
Dr. Terri Ann Gieske, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6239 E Brown Rd, Ste 113, Mesa, AZ 85205 Phone: 480-218-0663 Fax: 480-324-1494 |
 Verve Ophthalmic Group Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4824 E Baseline Rd Ste 140, Mesa, AZ 85206 Phone: 480-969-4040 Fax: 480-830-9202 |
Arizona Eye Institute, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 5110 S Power Rd, Mesa, AZ 85212 Phone: 480-281-0271 |
Evolution Vision Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1955 S Stapley Dr, Mesa, AZ 85204 Phone: 321-514-5833 |
Dr. Ernestine Leitman, O.D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1350 S Longmore, Suite 18, Mesa, AZ 85202 Phone: 480-655-0744 Fax: 480-655-1607 |
 Dustin Vermeulen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4824 E Baseline Rd, Suite 140, Mesa, AZ 85206 Phone: 480-969-4040 Fax: 480-830-9202 |
Riviera Opticare Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 555 N Gilbert Rd, Suite 101, Mesa, AZ 85203 Phone: 480-827-9184 |
News Archive
Portable, injectable clotting agent reduces blood loss by 97% in mice models
When it comes to traumatic injuries, it's a race against time. A person with major hemorrhage can die from blood loss within minutes, so staunching the wound and getting them to a hospital as fast as possible is critical.
CDR recommends reimbursement for schizophrenia drug, ABILIFY
Bristol-Myers Squibb Canada is pleased to announce that the Common Drug Review (CDR) has recognized the value of ABILIFY® (aripiprazole) for the treatment of schizophrenia and schizoaffective disorders by recommending it be reimbursed by provincial drug plans for patients who have a contraindication to less-expensive antipsychotic agents or who have failed a trial of less expensive antipsychotic agents due to intolerance or lack of response.
China strengthens safety of food products exported to United States
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People's Republic of China.
Prostate cancer therapy may benefit patients with oestrogen-negative breast cancer
CANCER RESEARCH UK Cancer Research UK scientists have discovered why a sub group of oestrogen-receptor-negative breast cancer patients could benefit from prostate cancer treatments which target the cell's androgen receptor - a key driver of prostate cancer, according to research published in The EMBO Journal today.
› Verified 6 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists